The Cigna Group (CI)
The Cigna Group (CI) Q2 2024 Earnings Call Transcript
The Cigna Group (NYSE:CI ) Q2 2024 Earnings Conference Call August 1, 2024 8:30 AM ET Company Participants Ralph Giacobbe - SVP of IR David Cordani - Chairman and CEO Brian Evanko - CFO, and President and CEO, Cigna Healthcare Eric Palmer - President and CEO, Evernorth Health Services Conference Call Participants Justin Lake - Wolfe Research Lisa Gill - JPMorgan A.J. Rice - UBS Andrew Mok - Barclays Scott Fidel - Stephens Ryan Langston - TD Cowen Josh Raskin - Nephron Research George Hill - Deutsche Bank Erin Wright - Morgan Stanley Stephen Baxter - Wells Fargo Dave Windley - Jefferies Jessica Tassan - Piper Sandler Lance Wilkes - Bernstein Operator Ladies and gentlemen, thank you for standing by for the Cigna Group Second Quarter 2024 Results Review.
Cigna (CI) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Cigna (CI) Q2 Earnings and Revenues Beat Estimates
Cigna (CI) came out with quarterly earnings of $6.72 per share, beating the Zacks Consensus Estimate of $6.42 per share. This compares to earnings of $6.13 per share a year ago.
Cigna beats profit estimates on lower-than-expected costs, pharmacy benefit boost
Cigna reported a second-quarter profit on Thursday that beat Wall Street estimates, helped by lower-than-expected medical costs and strength in its pharmacy benefit management unit.
Cigna Profits Hit $1.5 Billion On Pharmacy And Health Services Growth
The Cigna Group reported $1.5 billion in second quarter profits as the diversified provider of medical insurance, pharmacy benefits and health services reaped new clients.
Cigna (CI) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Can Cigna (CI) Beat Q2 Earnings on Growing Pharmacy Revenues?
Cigna's (CI) second-quarter earnings are expected to benefit from rising premiums and pharmacy revenues, partially offset by rising expenses.
Healthy Profits: 7 Healthcare Stocks to Build a Lifetime of Wealth
There are a whole host of reasons to invest in healthcare stocks over the long term. The United States has an aging population.
Wall Street's Insights Into Key Metrics Ahead of Cigna (CI) Q2 Earnings
Beyond analysts' top -and-bottom-line estimates for Cigna (CI), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.
Is Cigna Group (CI) Outperforming Other Medical Stocks This Year?
Here is how Cigna (CI) and atai Life Sciences N.V. (ATAI) have performed compared to their sector so far this year.
Cigna (CI) Reports Next Week: Wall Street Expects Earnings Growth
Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 HMO Stocks Set to Thrive on a Varied Customer Base, Tech Investments
Rising premiums, technological advancements and increased demand for Medicare plans are expected to drive the performances of the Zacks Medical-HMO industry players. UNH, CI and CNC are poised to benefit from encouraging industry prospects.
